<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/832846D7-4618-4AF0-9A40-838ED2236D1A"><gtr:id>832846D7-4618-4AF0-9A40-838ED2236D1A</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Latchman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9901318"><gtr:id>CA3BD33F-883A-4192-87D3-C27D850BE52D</gtr:id><gtr:title>Regulation of apoptosis in the developing nervous system by the antagonistic transcription factors Brn-3a and p53</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9901318</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>328983</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>291C43CA-0DEE-4C2F-98A4-D4CE7294165D</gtr:id><gtr:title>Brn-3a activates the expression of Bcl-x(L) and promotes neuronal survival in vivo as well as in vitro.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76afd7de3dc2cce787bb9810fab22a5c"><gtr:id>76afd7de3dc2cce787bb9810fab22a5c</gtr:id><gtr:otherNames>Smith MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn><gtr:outcomeId>pm_16287_17_11273642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E96DAAFE-44E7-44F9-8FAE-9FC0749CB24F</gtr:id><gtr:title>Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2917f149fdc886325e1086b99a28b5c6"><gtr:id>2917f149fdc886325e1086b99a28b5c6</gtr:id><gtr:otherNames>Hudson CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_16287_17_15598651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A85FCE5D-DF1D-477C-8AAB-5EB5825DD222</gtr:id><gtr:title>Sensory neurons from mice lacking the Brn-3b POU family transcription factor are resistant to death-inducing stimuli both in vitro and in vivo</gtr:title><gtr:parentPublicationTitle>MOLECULAR BRAIN RESEARCH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b67b39c24f76e913be3c10bc1130288"><gtr:id>7b67b39c24f76e913be3c10bc1130288</gtr:id><gtr:otherNames>Ensor E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0169-328X</gtr:issn><gtr:outcomeId>5a36066a137430.41828110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>869DED11-11E5-4CB7-A12B-C17E9EF5D0CB</gtr:id><gtr:title>Brn-3a/POU4F1 interacts with and differentially affects p73-mediated transcription.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2917f149fdc886325e1086b99a28b5c6"><gtr:id>2917f149fdc886325e1086b99a28b5c6</gtr:id><gtr:otherNames>Hudson CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_16287_17_18421303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A593B069-99E2-437B-96BF-E2CD88FD6EE2</gtr:id><gtr:title>Sensory neurons from mice lacking the Brn-3b POU family transcription factor are resistant to death-inducing stimuli both in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Brain research. Molecular brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b67b39c24f76e913be3c10bc1130288"><gtr:id>7b67b39c24f76e913be3c10bc1130288</gtr:id><gtr:otherNames>Ensor E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0169-328X</gtr:issn><gtr:outcomeId>pm_16287_17_14559155</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2383312B-EE33-4680-A266-1013E7676C74</gtr:id><gtr:title>The effects of Brn-3a on neuronal differentiation and apoptosis are differentially modulated by EWS and its oncogenic derivative EWS/Fli-1.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a975eba77331bf54b798a39b60eb7fb8"><gtr:id>a975eba77331bf54b798a39b60eb7fb8</gtr:id><gtr:otherNames>Gascoyne DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_16287_17_15021903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51F32C89-CE9A-44CD-97B6-1536C486AA3C</gtr:id><gtr:title>Coexpression of Brn-3a POU protein with p53 in a population of neuronal progenitor cells is associated with differentiation and protection against apoptosis.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2917f149fdc886325e1086b99a28b5c6"><gtr:id>2917f149fdc886325e1086b99a28b5c6</gtr:id><gtr:otherNames>Hudson CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0360-4012</gtr:issn><gtr:outcomeId>pm_16287_17_15532030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38BB5D70-8913-412F-8AC1-E5C094130BC5</gtr:id><gtr:title>The BRN-3A transcription factor protects sensory but not sympathetic neurons from programmed cell death/apoptosis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b67b39c24f76e913be3c10bc1130288"><gtr:id>7b67b39c24f76e913be3c10bc1130288</gtr:id><gtr:otherNames>Ensor E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_16287_17_11053412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E322E6DB-8137-451C-B2D0-733A7844C98B</gtr:id><gtr:title>The POU domain transcription factor Brn-3a protects cortical neurons from apoptosis.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76afd7de3dc2cce787bb9810fab22a5c"><gtr:id>76afd7de3dc2cce787bb9810fab22a5c</gtr:id><gtr:otherNames>Smith MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn><gtr:outcomeId>pm_16287_17_11711852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E77A3707-1CB0-4350-B2A0-C751CC317C77</gtr:id><gtr:title>Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/498c0b3c9f5636bfd52257783ea5bd75"><gtr:id>498c0b3c9f5636bfd52257783ea5bd75</gtr:id><gtr:otherNames>Budhram-Mahadeo VS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_16287_17_17145718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>378AE8D4-0E76-45FF-8624-6E5046B12422</gtr:id><gtr:title>The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21(CIP1/Waf1).</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5edf432ff6adad4111b3153bb6e1db43"><gtr:id>5edf432ff6adad4111b3153bb6e1db43</gtr:id><gtr:otherNames>Budram-Mahadeo V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>54731e26be9397.82815036</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9901318</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>